Document is current
Any future updates will be listed below
-
Authors
Zheng, Shan
Zuo, Jie
Chen, Manxiang
Han, Tian
Gao, Lina
Pang, Tieliang
Guo, Lei
Liang, Jing
Feng, Zitong
Zhang, Zhiyi
Shou, Jianzhong
Ying, Jianming
-
Funding
Funding for this research was provided by:
National High Level Hospital Clinical Research Funding and Beijing Hope Run Special Fund of Cancer Foundation of China (LC2022A11)
National Natural Science Foundation of China (82072837)
- License Information
-
More Information
Article History
Received: 24 January 2026
Accepted: 13 March 2026
First Online: 25 March 2026
Declarations
:
: This study was in compliance with the Declaration of Helsinki and was approved by the Ethics Committee of National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Ethics Approval No: 23/095-3843). The requirement of informed written consent to the participates was waived by the Ethics Committee of National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. The study was conducted in accordance with the local legislation and institutional requirements.
: Not applicable.
: Jie Zuo, Tieliang Pang, Zhiyi Zhang are employees of Biotecnovo (Beijing) Co. Ltd. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
